Money from the private placement will be used for general corporate and working capital purposes, including activities supporting its ICE COLD-PCR technology.
In PLOS this week: loci linked to protection against tuberculosis, identification of loci associated with increased risk of squamous cell carcinoma of the aerodigestive tract, and more.